7 research outputs found
Assessment of temozolomide action encapsulated in chitosan and polymer nanostructures on glioblastoma cell lines
Purpose: Glioblastoma multiforme (GBM) remains one of the most devastating diseases known to mankind and affects more than 17,000 patients in the United States alone every year. This malignancy infiltrates the brain early in its course and makes complete neurosurgical resection almost impossible. Recent years have brought significant advances in tumor biology. Many cancers, including gliomas, appear to be supported by cells with stem-like properties. Nanoparticles are excellent candidates to serve as delivery vectors of drugs or biologically active molecules because of their unique chemical and physical properties that result in specific transportation and deposition of such agents in specific organs and tissues.In the current study we have investigated the in vitro action of nanostructural systems (temozolomide encapsulated in chitosan and polymer nanostructures) on high-grade glioma-derived cancer stem cells (CSCs), with the intention of developing a new therapy to treat specific brain tumors with increased efficacy and minimal toxicity. In vitro cytotoxicity and apoptosis measurements indicated that the drug/vector combination facilitated the ability of the alkylating drug TMZ to alter the resistance of these cancer stem cells, suggesting a new chemotherapy strategy even for patients diagnosed with inoperable or recurrent malignant gliomas.Methods: At the National Institute for R & D of Isotopic and Molecular Technologies form Cluj Napoca were synthesized three types of nanostructures chitosan-TMZ, TMZ-chitosan-PEG (poly-ethylene glycol), TMZ-chitosan-PPG (polypropylene glycol). Three type of cell lines (Glioma-derived stem, HFL and HUVEC) were treated with the 3 types of nanostructures and the survival rate of the cells was compare to standard therapy (TMZ).Results: The results showed a reduction in the rate of survival of the tumor cells. Cell proliferation assays clearly demonstrate the differences between conventional chemotherapy (TMZ) and temozolomide encapsulated in chitosan and polymer nanostructures. Conclusion: Nanostructures like chitosan, PEG, PPG are useful as vectors for drugs transport.Despite combined therapy (surgery, radiotherapy, chemotherapy), currently median patient survival is reduced. The key to improving life expectancy could be an effective therapy targeted, customized for each case. An increasingly important role will be new methods of treatment such as immunotherapy, gene therapy or nanotherapy
Efects of PDT with 5-aminolevulinic acid and chitosan on Walker carcinosarcoma
Porphyrins and new chitosan hydrogels based composites with porphyrins are used as active cytotoxic antitumor agents in photodynamic therapy (PDT). Aim: The present study evaluates the effects of photodynamic therapy (PDT) with 5-aminolevulinic acid (5-ALA) and 5-ALA associated with chitosan (CS) using Walker carcinosarcoma in rats as experimental model. Methods: The animals were irradiated with red light (l = 685 nm, D = 50 J/cm2, 15 min) 3 h after i.p. administration of 5-ALA (250 mg/kg b.w.) or a mixture of 5-ALA (250 mg/kg b.w.) and CS (1.5 mg/kg b.w.). The animals were sacrificed at 1, 3, 6, 24 h and 14 days after the treatment. The effects of PDT were investigated by morphological studies, monitoring the 5-ALA induced protoporphyrin IX (Pp IX) level in tumor tissue and serum, MMP 2 and 9 (gelatinases) activity in tumor and malondialdehyde level (MDA), marker of the lipoperoxidation process, in tumor and serum. Results: Zymography revealed an increased activity of MMP 2 in tumors from animals treated with 5-ALA PDT. PDT with 5-ALA induced a higher lipid peroxidation in tumor tissue compared with 5-ALA-CS. CS associated to 5 ALA PDT enhanced the accumulation of PS in tumors inducing earlier necrotic changes. In the same time CS reduced MMP 2 activity. Conclusion: Our results suggest that MMPs activation and oxygen reactive species are involved in PDT effects.ΠΠΎΡΡΠΈΡΠΈΠ½Ρ ΠΈ Π½ΠΎΠ²ΡΠ΅ ΡΠΎΠ΅Π΄ΠΈΠ½Π΅Π½ΠΈΡ, ΠΎΡΠ½ΠΎΠ²Ρ ΠΊΠΎΡΠΎΡΡΡ
ΡΠΎΡΡΠ°Π²Π»ΡΡΡ Π³ΠΈΠ΄ΡΠΎΠ³Π΅Π»ΠΈ Ρ
ΠΈΡΠΎΠ·Π°Π½Π° Ρ ΠΏΠΎΡΡΠΈΡΠΈΠ½Π°ΠΌΠΈ, ΠΈΡΠΏΠΎΠ»ΡΠ·ΡΡΡΡΡ ΠΊΠ°ΠΊ Π°ΠΊΡΠΈΠ²Π½ΡΠ΅
ΡΠΈΡΠΎΡΠΎΠΊΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΏΡΠΎΡΠΈΠ²ΠΎΠΎΠΏΡΡ
ΠΎΠ»Π΅Π²ΡΠ΅ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΡ ΠΏΡΠΈ ΡΠΎΡΠΎΠ΄ΠΈΠ½Π°ΠΌΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ (PDT). Π¦Π΅Π»Ρ: ΠΎΡΠ΅Π½ΠΈΡΡ Π΄Π΅ΠΉΡΡΠ²ΠΈΠ΅
PDT Ρ 5-Π°ΠΌΠΈΠ½ΠΎΠ»Π΅Π²ΡΠ»Π΅Π½ΠΎΠ²ΠΎΠΉ ΠΊΠΈΡΠ»ΠΎΡΠΎΠΉ (5-ALA) ΠΈ 5-ALA, Π°ΡΡΠΎΡΠΈΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠΉ Ρ Ρ
ΠΈΡΠΎΠ·Π°Π½ΠΎΠΌ (CS), Π½Π° ΠΊΠ»Π΅ΡΠΊΠΈ ΠΊΠ°ΡΡΠΈΠ½ΠΎΡΠ°ΡΠΊΠΎΠΌΡ
Π£ΠΎΠΊΠ΅ΡΠ°. ΠΠ΅ΡΠΎΠ΄Ρ: ΠΊΡΡΡ ΠΎΠ±Π»ΡΡΠ°Π»ΠΈ ΠΊΡΠ°ΡΠ½ΡΠΌ ΡΠ²Π΅ΡΠΎΠΌ (Ξ» = 685 Π½ΠΌ, D = 50 ΠΠΆ/ΡΠΌ2
, 15 ΠΌΠΈΠ½) 3 Ρ ΠΏΠΎΡΠ»Π΅ Π²Π½ΡΡΡΠΈΠ±ΡΡΡΠΈΠ½Π½ΠΎΠ³ΠΎ Π²Π²Π΅Π΄Π΅Π½ΠΈΡ
5-ALA (250 ΠΌΠ³/ΠΊΠ³) ΠΈΠ»ΠΈ ΡΠΌΠ΅ΡΠΈ 5-ALA (250 ΠΌΠ³/ΠΊΠ³) ΠΈ CS (1,5 ΠΌΠ³/ΠΊΠ³). ΠΠΎΠ΄ΠΎΠΏΡΡΠ½ΡΡ
ΠΆΠΈΠ²ΠΎΡΠ½ΡΡ
Π·Π°Π±ΠΈΠ²Π°Π»ΠΈ ΡΠ΅ΡΠ΅Π· 1 Ρ, 3 Ρ, 6 Ρ,
24 Ρ ΠΈ 14 Π΄Π½Π΅ΠΉ ΠΏΠΎΡΠ»Π΅ Π²ΠΎΠ·Π΄Π΅ΠΉΡΡΠ²ΠΈΡ PDT. ΠΡΡΠ΅ΠΊΡ PDT ΠΎΠΏΡΠ΅Π΄Π΅Π»ΡΠ»ΠΈ Ρ ΠΏΠΎΠΌΠΎΡΡΡ ΠΌΠΎΡΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΉ, ΡΠ΅Π³ΠΈΡΡΡΠΈΡΡΡ
ΡΡΠΎΠ²Π΅Π½Ρ ΠΏΡΠΎΡΠΎΠΏΠΎΡΡΠΈΡΠΈΠ½Π° IX (Pp IX), Π²ΡΠ·ΡΠ²Π°Π΅ΠΌΠΎΠ³ΠΎ 5-ALA, Π² ΠΎΠΏΡΡ
ΠΎΠ»Π΅Π²ΠΎΠΉ ΡΠΊΠ°Π½ΠΈ ΠΈ ΡΡΠ²ΠΎΡΠΎΡΠΊΠ΅ ΠΊΡΠΎΠ²ΠΈ, Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ MMP 2 ΠΈ 9
(ΠΆΠ΅Π»Π°ΡΠΈΠ½Π°Π·Ρ) Π² ΠΎΠΏΡΡ
ΠΎΠ»ΠΈ ΠΈ ΡΡΠΎΠ²Π΅Π½Ρ ΠΌΠ°Π»ΠΎΠ½ΠΎΠ²ΠΎΠ³ΠΎ Π΄ΠΈΠ°Π»ΡΠ΄Π΅Π³ΠΈΠ΄Π° (MDA), ΠΌΠ°ΡΠΊΠ΅ΡΠ° ΠΏΡΠΎΡΠ΅ΡΡΠ° ΠΏΠ΅ΡΠ΅ΠΊΠΈΡΠ½ΠΎΠ³ΠΎ ΠΎΠΊΠΈΡΠ»Π΅Π½ΠΈΡ Π»ΠΈΠΏΠΈΠ΄ΠΎΠ², Π²
ΠΎΠΏΡΡ
ΠΎΠ»ΠΈ ΠΈ ΡΡΠ²ΠΎΡΠΎΡΠΊΠ΅ ΠΊΡΠΎΠ²ΠΈ. Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ: Π·ΠΈΠΌΠΎΠ³ΡΠ°ΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ ΠΏΠΎΠΊΠ°Π·Π°Π»ΠΈ ΠΏΠΎΠ²ΡΡΠ΅Π½Π½ΡΡ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ MMP 2 Π²
ΠΎΠΏΡΡ
ΠΎΠ»ΡΡ
ΠΆΠΈΠ²ΠΎΡΠ½ΡΡ
, ΠΊΠΎΡΠΎΡΡΡ
ΠΏΠΎΠ΄Π²Π΅ΡΠ³Π°Π»ΠΈ 5-ALA PDT. PDT Ρ 5-ALA Π²ΡΠ·ΡΠ²Π°Π»Π° ΠΏΠΎΠ²ΡΡΠ΅Π½Π½ΡΠΉ ΡΡΠΎΠ²Π΅Π½Ρ ΠΏΠ΅ΡΠ΅ΠΊΠΈΡΠ½ΠΎΠ³ΠΎ ΠΎΠΊΠΈΡΠ»Π΅Π½ΠΈΡ
Π»ΠΈΠΏΠΈΠ΄ΠΎΠ² Π² ΠΎΠΏΡΡ
ΠΎΠ»Π΅Π²ΠΎΠΉ ΡΠΊΠ°Π½ΠΈ ΠΏΠΎ ΡΡΠ°Π²Π½Π΅Π½ΠΈΡ Ρ 5-ALA-CS. CS Ρ 5 ALA PDT ΡΡΠΈΠ»ΠΈΠ²Π°Π» Π½Π°ΠΊΠΎΠΏΠ»Π΅Π½ΠΈΠ΅ ΡΠΎΡΠΎΡΠ΅Π½ΡΠΈΠ±ΠΈΠ»ΠΈΠ·ΠΈΡΡΡΡΠ΅Π³ΠΎ
Π²Π΅ΡΠ΅ΡΡΠ²Π° (PS) Π² ΠΎΠΏΡΡ
ΠΎΠ»ΡΡ
, Π²ΡΠ·ΡΠ²Π°Ρ Π±ΠΎΠ»Π΅Π΅ ΡΠ°Π½Π½ΠΈΠ΅ Π½Π΅ΠΊΡΠΎΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΡ. Π ΡΠΎ ΠΆΠ΅ Π²ΡΠ΅ΠΌΡ CS ΡΠ½ΠΈΠΆΠ°Π» Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ MMP 2.
ΠΡΠ²ΠΎΠ΄Ρ: ΠΏΠΎΠ»ΡΡΠ΅Π½Π½ΡΠ΅ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΡ ΠΏΠΎΠ·Π²ΠΎΠ»ΡΡΡ ΠΏΡΠ΅Π΄ΠΏΠΎΠ»ΠΎΠΆΠΈΡΡ, ΡΡΠΎ Π΄Π»Ρ ΠΏΡΠΎΡΠ²Π»Π΅Π½ΠΈΡ ΡΡΡΠ΅ΠΊΡΠΎΠ² PDT Π½Π΅ΠΎΠ±Ρ
ΠΎΠ΄ΠΈΠΌΡ Π°ΠΊΡΠΈΠ²Π°ΡΠΈΡ
MMP ΠΈ ΠΎΠ±ΡΠ°Π·ΠΎΠ²Π°Π½ΠΈΠ΅ Π°ΠΊΡΠΈΠ²Π½ΡΡ
ΡΠΎΡΠΌ ΠΊΠΈΡΠ»ΠΎΡΠΎΠ΄Π°
Characteristics of Formvar Films Used to Prevent Alpha-Detector Contamination
Alpha spectrometry is an extremely useful and sensitive for detection of alpha-emitting nuclides. Contamination of the silicon detectors for low-level alpha spectrometry by recoil nuclides is a serious problem in the measurement of alpha emitters decaying to daughter nuclides with short half-lives. This unwanted contamination leads to decreased measurement sensitivity causing a degradation of the limit of detection. The simplest method to prevent this radioactive contamination of detector is to use a catcher film between the alpha source and the detector. In this work we describe the obtaining of the thin formvar films as stopper foils for recoil nuclei and we investigated the influence of these films on alpha spectrometry parameters, as energy shift (~30 keV) and resolution (~7%). No significant deterioration of the alpha spectrometry parameters was observed when using thin formvar films. Using the ASTAR web databases, which calculate stopping powers for alpha particles, the thickness of formvar films was estimated to be about 5.355 Γ 10β5 g/cm2. The measurements were performed with an ORTEC SOLOIST alpha spectrometer with PIPS detector